Effect of the COVID-19 pandemic on patients with inherited neuromuscular disorders
Authors:
- Cristiane Araujo Martins MorenoCMCristiane Araujo Martins Moreno
- Clara Gontijo CameloCCClara Gontijo Camelo
- Pedro Henrique Marte de Arruda SampaioPSPedro Henrique Marte de Arruda Sampaio
- Alulin Tácio Quadros Santos Monteiro FonsecaAFAlulin Tácio Quadros Santos Monteiro Fonseca
- Eduardo de Paula EstephanEEEduardo de Paula Estephan
- André Macedo Serafim SilvaASAndré Macedo Serafim Silva
- Renann Nunes PirolaRPRenann Nunes Pirola
- Luiz Henrique Libardi SilvaLSLuiz Henrique Libardi Silva
- Karlla Danielle Ferreira LimaKLKarlla Danielle Ferreira Lima
- Marco Antônio Veloso de AlbuquerqueMAMarco Antônio Veloso de Albuquerque
- Antonio Edvan Camelo FilhoAFAntonio Edvan Camelo Filho
- Marcos Vinícius Oliveira MarquesMMMarcos Vinícius Oliveira Marques
Open Access
- 8 August 2022
- journal article
- research article
- Published by FapUNIFESP (SciELO) in Arquivos de Neuro-Psiquiatria
- Vol. 80 (6) , 563-569
Abstract
Background The COVID-19 pandemic has brought substantial challenges for current practices in treating hereditary neuromuscular disorders (hNMDs). However, this infection has not been the only concern for these patients. Social distancing has compromised multidisciplinary assistance and physical activity, and has brought about several mental health issues. We presented a follow-up on 363 patients with hNMDs at a Brazilian tertiary center during the peak of the COVID-19 pandemic. Objective We aimed to show the frequency and severity of SARS-CoV-2 infection among hNMD patients and to demonstrate the effects of the pandemic on life habits, disease progression and multidisciplinary supportive care status. Methods Three hundred and sixty-three patients (58% male and 42% female) were followed for three months through three teleconsultations during the peak of the COVID-19 pandemic in Brazil. Results There were decreases in the numbers of patients who underwent physical, respiratory and speech therapies. For several patients, their appetite (33%) and sleep habits (25%) changed. Physical exercises and therapies were interrupted for most of the patients. They reported new onset/worsening of fatigue (17%), pain (17%), contractions (14%) and scoliosis (7%). Irritability and sleep, weight and appetite changes, and especially diminished appetite and weight loss, were more frequent in the group that reported disease worsening. There was a low COVID-19 contamination rate (0.8%), and all infected patients had a mild presentation. Conclusion The isolation by itself was protective from a COVID-19 infection perspective. However, this isolation might also trigger a complex scenario with life habit changes that are associated with an unfavorable course for the NMD.Keywords
This publication has 14 references indexed in Scilit:
- Guillain-Barré syndrome: The first documented COVID-19–triggered autoimmune neurologic diseaseNeurology Neuroimmunology & Neuroinflammation, 2020
- Ethical decision-making for children with neuromuscular disorders in the COVID-19 crisisNeurology, 2020
- Mental Health and the Covid-19 PandemicNew England Journal of Medicine, 2020
- Significant reduction of physical activity in patients with neuromuscular disease during COVID-19 pandemic: the long-term consequences of quarantineJournal of Neurology, 2020
- Rapid implementation of virtual neurology in response to the COVID-19 pandemicNeurology, 2020
- COVID-19 and neuromuscular disordersNeurology, 2020
- Guidance for the care of neuromuscular patients during the COVID-19 pandemic outbreak from the French Rare Health Care for Neuromuscular Diseases NetworkRevue Neurologique, 2020
- Spinal muscular atrophy care in the COVID‐19 pandemic eraMuscle & Nerve, 2020
- Treating pediatric neuromuscular disorders: The future is nowAmerican Journal of Medical Genetics Part A, 2017
- Neuromuscular Disorders in Children and AdolescentsNeuropediatrics, 2017